Physician profile
Robert W Sullivan
NPI 1669445300
$5,586.08
in general payments reported to CMS, 2019-2025
18 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $1,455 · 2021: $355 · 2022: $1,952 · 2023: $978 · 2024: $243 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,659.37 | 2019-2025 | Citrefix, Augment Injectable, Prostep |
| Fortis Surgical, LLC | $1,344.00 | 2020 | |
| Treace Medical Concepts, INC. | $965.70 | 2022 | |
| Anika Therapeutics, INC. | $226.48 | 2023 | Tactoset, Toe Motion, Twist |
| Organogenesis INC. | $220.64 | 2019-2022 | |
| Smith+Nephew, INC. | $185.59 | 2020-2024 | Collagenase Santyl |
| Bioventus LLC | $181.94 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $144.29 | 2023 | Promogran Prisma, Activ.A.C., V.A.C. Veraflo |
| Misonix INC | $143.12 | 2019 | |
| Integra Lifesciences Corporation | $126.26 | 2019-2022 | |
| Wright Medical Technology, INC. | $123.43 | 2019-2020 | |
| Heron Therapeutics, INC. | $98.40 | 2022 | |
| Linvatec Corporation | $65.16 | 2023 | Colink Plating System |
| Abbott Laboratories | $26.66 | 2021 | |
| Convatec INC. | $23.86 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $23.35 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.11 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.